Mesenchymal stem cells/marrow stromal cells (MSCs) present a promising tool for cell
therapy, and are currently being tested in US FDA-approved clinical trials for myocardial …

Galectin 3 is a member of a family of β-galactoside binding proteins and has emerged as an
important regulator of diverse functions critical in cancer biology including apoptosis …

Valid experimental evidence has recently shown that progression of malignant tumors does
not depend exclusively on cell-autonomous properties of the cancer cells, but is also deeply …

Multipotent mesenchymal stromal/stem cells (MSC) have shown potential clinical utility.
However, previous assessments of MSC behavior in recipients have relied on visual …

Abstract Rationale: Extracellular vesicles (EVs) have emerged as novel mediators of cell-to-
cell communication that are capable of the stable transfer of therapeutic microRNAs …

Research on stem cells has progressed at a rapid pace and, as might be anticipated, the
results have generated several controversies, a few myths and a change in a major …

Over the last decade, there has been a growing interest in the role of mesenchymal stem
cells (MSC) in cancer progression. These cells have the potential to give rise to a variety of …

Cell-based therapy is a promising modality to address many unmet medical needs. In
addition to genetic engineering, material-based, biochemical, and physical science-based …

This review provides an overview of animal models for the evaluation, comparison, and
systematic optimization of tissue engineering and regenerative medicine strategies related …

Paradigm I: the haematopoietic niche• Paradigm II: engraftment/differentiation‐Early
observations on engraftment and differentiation‐Technical challenges in testing paradigm II …